Va2 Phiii
Research payments
$47,549,098
Through program year 2025, $47,549,098 in research payments was reported against Va2 Phiii, across 2,061 payments.
- Paid by (largest first)
- Genentech, Inc.; F. Hoffmann-La Roche AG
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
7 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | Research | $38,292 | 43 |
| 2024 | Research | $257,348 | 81 |
| 2023 | Research | $756,402 | 54 |
| 2022 | Research | $3,835,918 | 193 |
| 2021 | Research | $16,853,672 | 651 |
| 2020 | Research | $19,276,022 | 696 |
| 2019 | Research | $6,531,445 | 343 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Arshad Khanani Reno, NV Named on 46 payments
- David Brown Houston, TX Named on 39 payments
- Stephen Huddleston Germantown, TN Named on 33 payments
- David Eichenbaum Saint Petersburg, FL Named on 28 payments
- Ivan Suner Tampa, FL Named on 27 payments
- Sunil Patel Abilene, TX Named on 25 payments
- Golnaz Javey Lynchburg, VA Named on 24 payments
- David Parke Minneapolis, MN Named on 22 payments
- John Wells West Columbia, SC Named on 21 payments
- Vrinda Hershberger Melbourne, FL Named on 21 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.